Biotech Showcase: the Investor Conference for Innovators 2022 - San Francisco | Informa Connect | 10 January 2022 | Virtual event

Engage With Global Investors & Life Sciences Executives
• Re-connect With Peers
It's up to you if you want to join in person or digitally. Either way, Biotech Showcase will give you the opportunity to re-connect with your peers via seamless one-to-one networking in partneringONE®.

• Present Your Company
You will have the opportunity to showcase your innovations via a pre-recorded presentation, which will be available on-demand to all registered attendees two weeks prior to the start of the event.

• Learn From Industry Leaders
Hear the latest industry trends in workshops and panels featuring key biotech leaders, investors, pharma executives, and other industry advisors.

• Calling Startup Companies
As a startup, meeting the right investors and getting in front of the right decision-makers during the most important fund-raising week of the year is crucial.
Seed Showcase - part of Biotech Showcase can help you get there.

• Find Your Next Investment
This event gives you the opportunity to find thousands of investment opportunities. Participating companies are ranging from early, mid to later stage. From Startup, over Biotech and large Pharma.

Jeremy Abbate
Publisher
Scientific American

Gautam Aggarwal
Partner
Triangle Insights Group, LLC

Jill Angelo
CEO
Gennev

Jim Anthony
EVP and Global Head
Parexel Biotech

Mara Aspinall
Managing Director
Health Catalysts Group

Phyllis Barkman
Global Head, External Engagement, Alzheimer’s disease and Neurodegeneration
Eli Lilly & Company

Travis Bond
CEO
Altoida, Inc.

Ben Bonifant
Partner
Triangle Insights

Rick Bright
CEO, Pandemic Prevention Institute and Senior VP
Pandemic Prevention & Response, Health Initiative, The Rockefeller Foundation

Michael Brooks
Chief Development Officer and Global Head, Clinical Development Solutions
Syneos Health

Susan Cantrell
CEO
Academy of Managed Care Pharmacy (AMCP)

Gabriel P. Cavazos
Managing Director, Investment Banking
SVB Leerink

Erik Clausen
Managing Director
CG Life

Karin Conde-Knape
Senior VP Global Drug Discovery
Novo Nordisk

Everett Crosland
CCO
Cognito Therapeutics

Alice Valder Curran
Partner
Hogan Lovells

Michael Davitian
VP
Health Advances

Kevin DeGeeter
Healthcare Research
Oppenheimer & Co. Inc.

Sara Jane Demy
CEO and Founder
Demy-Colton

Bob Dougherty
VP
Digital Health Research

Doug Drysdale
CEO
Cybin

Simone Fishburn
VP and Editor in Chief
BioCentury

Mani Foroohar
Managing Director, Senior Research Analyst
Leerink Partners

Maria Fotiu
Executive VP of Decentralized Solutions
Syneos Health

Adam Gazzaley
Distinguished Professor of Neurology, Physiology & Psychiatry
UC San Francisco

Jennifer Friel Goldstein
Managing Partner, Life Science and Healthcare
SVB Capital

Miranda Gottlieb
Venture Partner
Pappas Capital

Walter Greenleaf
Distinguished Visiting Scholar
Stanford University’s MediaX Program

Ted Haack
VP
Lattice Point Consulting

Katya Hancock
Investment Network Director
StartUp Health

Paul J. Hastings
President and CEO
Nkarta Therapeutics, Inc.

Kevin Healy
Senior VP, Regulatory Affairs, Pharmacovigilance, and Quality
Enzyvant

William Ho
CEO
In8bio

Beth Hoffman
Founder and CEO
Origami Therapeutics, Inc.

Alison Holland
Head of Decentralized and Remote Trials
Medable

Chihiro Hosoya
Head of Venture Management and Business Development
Astellas Rx+ Business Accelerator

Rachelle Jacques
CEO
Enzyvant

Ben Johnson
Head of Early Stage Life Science
Silicon Valley Bank

Bryan Katz
Senior VP and Global Head, Solution Development
Syneos Health

David J. Kim
Managing Director
DigiTx Partners

Susan Kitlas
VP
Precommercial Segment Lead, IQVIA

Tomas Landh
Innovation Sourcing VP, Senior Principal Scientist, R&D Global Search & Evaluation
Novo Nordisk

Francesco Lavino
CEO
F2G

Martin Lehr
CEO and Director
Context Therapeutics

Jeremy Levin
CEO and Board of Directors Chair
Ovid Therapeutics, BIO

Michelle Longmire
CEO and Co-Founder
Medable

Philippe Lopes-Fernandes
Executive VP and CBO
Ipsen

Jamie Macdonald
CEO
Parexel

Yuri Maricich
CMO and Head of Development
Pear Therapeutics

Todd Matthews
Senior Director
Corporate Alliances, IQVIA

Mariana Matus
CEO and Co-Founder
Biobot Analytics

Owen McCarthy
President and Founder
MedRhythms

John McDonald
Corporate VP, Global R&D Business Development
Novo Nordisk

Michael McFadden
CEO
Alpha Cognition, Inc.

Michelle McMurry-Heath
President and CEO
USA

Michelle McMurry-Heath
President and CEO
Biotechnology Innovation Organization (BIO)

Matt Miller
CEO
StudyKIK

David Moore
Partner
Gurnet Point Capital

Juliet Moritz
COO
Illingworth Research

Matthias Muellenbeck
Senior VP, Head Global BD&L
Merck Group

Naveen Murthy
Senior Managing Director, Head of Product & Franchise Strategy, Commercial Advisory Group, Consulting
Syneos Health

Marian Nakada
VP, Venture Investments
Johnson & Johnson Innovation, JJDC

James R. Neal
CEO and Member, Board of Directors
XOMA

Crystal Nyitray
CEO
Encellin

Robert O'Brien
VP
Real Endpoints

Tim Opler
Partner & Co-Founder
Torreya

Art Pappas
Managing Partner
Pappas Capital

Neel Patel
Executive Managing Director, Head Commercial Advisory Group - Consulting
Syneos Health Consulting

Kelliann Payne
Partner
Hogan Lovells

Tanya Petrossian
CEO
EndoCyclic Therapeutics

Catherine Phillips
Innovation Architect
Heathrow Airport

Karen Pihel
Senior Director, CMC Regulatory Affairs
Enzyvant

Logan Plaster
Director and Editor-in-Chief
StartUp Health

Myrtle Potter
CEO
Sumitovant

Dennis J. Purcell
Founder and Senior Advisor
Aisling Capital

Sachin Purwar
Director of Commercial Advisory Group, Consulting
Syneos Health

Kanya Rajangam
CMO
Nkarta Therapeutics

Lisa Ricciardi
CEO
Cognition Therapeutics, Inc.

Liz Rockett
Managing Director
Kaiser Permanente Ventures

Beth Rogozinski
CEO
Oncoustics

Spiro Rombotis
President and CEO
Cyclacel Pharmaceuticals

Peter Rubin
Executive Director
No Patient Left Behind

Camille Samuels
Partner
Venrock

Michael Sarshad
Director of Commercial Advisory Group, Consulting
Syneos Health

Sam Scarpino
Managing Director
Pathogen Surveillance

Greg Scott
Founder and Chairman
ChinaBio® Group

Nadeem Sheikh
VP, Research and Manufacturing Sciences
Dendreon

Ed Silverman
Senior Writer and Pharmalot Columnist
STAT

Juliane Snowden
XOMA

Komathi Stem
COO
Glooko

Helen Stembridge
UKHSA Strategic Engagement and Director of Projects
WholeShip Consulting Ltd

Andrew Strong
Partner
Hogan Lovells

Melita Sun Jung
CBO
ShouTi

Weimin Tang
CBO
I-Mab Biopharma

John Vandermosten
Senior Biotechnology Analyst
Zacks Small Cap Research

Brent Vaughan
CEO
Cognito Therapeutics

Larry Weiner
VP of Pharmaceutical Development & Manufacturing
Enzyvant

Eugene Williams
Chairman and CEO
ProMIS Neurosciences

Mylene Yao
CEO
Univfy

Berra Yazar-Klosinski
CSO
Multidisciplinary Association for Psychedelic Studies (MAPS)

Debra Yu
President and CSO
LianBio

Lihua Zheng
CBO and Co-Founder
AnHeart Therapeutics

Maryam Ziaei-Moayyed
CEO
iSono Health

PLATINUM SPONSORS:

Curia Global
Cybin
Enzyvant
FUJIFILM Diosynth Biotechnologies
Hogan Lovells
IQVIA
Medable
Parexel
Syneos Health
XOMA